
Google Maps Labels U.S. as “Sensitive Country” Amid Trump’s Name Change Orders
Jan 29, 2025 04:09 am UTC| Technology Business
Googles Maps division has reclassified the U.S. as a sensitive country, a designation typically used for nations with strict governments or disputed borders, CNBC reported. The move coincides with former President Donald...

Robinhood CEO Vlad Tenev: Blockchain Can Open Private Markets to Retail Investors
Jan 29, 2025 04:09 am UTC| Technology Business Fintech Digital Currency
Vlad Tenev, CEO and co-founder of Robinhood Markets Inc. (NASDAQ:HOOD), believes blockchain technology could revolutionize investing by granting retail investors access to private markets dominated by institutions and...

NATO and Denmark Discuss Arctic Defense Amid U.S. Greenland Interest
Jan 29, 2025 04:08 am UTC| Politics Business
NATO Secretary-General Mark Rutte and Danish Prime Minister Mette Frederiksen emphasized the need for stronger Arctic defenses during their meeting on Tuesday, a source told Reuters. Both leaders agreed that all NATO...

U.S. Probes Chinese AI App DeepSeek Over Security and Innovation Threats
Jan 29, 2025 04:08 am UTC| Technology Business
The U.S. government is examining the national security risks posed by the Chinese AI app DeepSeek, White House press secretary Karoline Leavitt announced. The National Security Council is reviewing its implications,...

MicroStrategy: A Levered Bet on Bitcoin's Growth Amid Crypto-Friendly U.S. Regulations
Jan 29, 2025 04:07 am UTC| Digital Currency Business Law
MicroStrategy Incorporated (NASDAQ:MSTR) has been rated Buy by Compass Point Research, citing the stock as a leveraged opportunity tied to Bitcoins upward potential. Compass Point initiated coverage with a $550 price...

Zimmer Biomet to Acquire Paragon 28 for $1.1 Billion, Expanding Orthopedic Portfolio
Jan 29, 2025 04:07 am UTC| Business
Zimmer Biomet announced plans to acquire medical device company Paragon 28 for $1.1 billion, enhancing its range of orthopedic surgical devices. This strategic move strengthens Zimmers offerings in fracture, trauma, and...

FDA Approves Ozempic for Kidney and Heart Protection in Diabetic Patients
Jan 29, 2025 04:06 am UTC| Business
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisks (NYSE:NVO) Ozempic for reducing the risk of kidney failure, disease progression, and death due to heart issues in diabetes patients with chronic kidney...